Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Revenues	$ 55,474	$ 11,280	$ 96,177	$ 29,472
Cost of revenues	50,516	8,817	87,484	25,598
Gross profit	4,958	2,463	8,693	3,874
Operating expenses:
Research and development, net	19,165	8,529	32,642	15,607
Selling, general and administrative	18,952	7,068	42,030	13,692
Total operating expenses	38,117	15,597	74,672	29,299
Operating loss	(33,159)	(13,134)	(65,979)	(25,425)
Other income (expense):
Interest expense, net	(2,432)	(275)	(5,421)	(402)
Loss on foreign exchange	(3,876)	(126)	(3,896)	(405)
Change in fair value of liability classified warrants	0	(2,448)	13,482	(5,478)
Other income (expense), net	(23)	(242)	3	(133)
Total other income (expense), net	(6,331)	(3,091)	4,168	(6,418)
Loss before income taxes	(39,490)	(16,225)	(61,811)	(31,843)
Benefit (provision) for income taxes	2,073	(440)	(2,315)	(704)
Net loss	(37,417)	(16,665)	(64,126)	(32,547)
Other comprehensive income (loss), net of tax:
Foreign currency translation income (loss)	(1,030)	333	(154)	1,074
Comprehensive loss	$ (38,447)	$ (16,332)	$ (64,280)	$ (31,473)
Net loss per share attributable to Rocket Lab USA, Inc.:
Net loss per share attributable to common stockholders-basic	$ (0.08)	$ (0.21)	$ (0.14)	$ (0.41)
Net loss per share attributable to common stockholders- diluted	$ (0.08)	$ (0.21)	$ (0.14)	$ (0.41)
Weighted-average common shares outstanding:
Weighted average common shares outstanding-basic	464,719,924	78,961,096	460,630,324	78,893,969
Weighted average common shares outstanding, diluted	464,719,924	78,961,096	460,630,324	78,893,969